De novo ligand design with explicit water molecules: an application to bacterial neuraminidase.
Most computer-aided drug design methods ignore the presence of crystallographically-determined water molecules in the binding site of a target protein. In this paper, our de novo ligand design methods are applied to the X-ray crystal structure of bacterial neuraminidase in the presence of some selected water molecules. We have found that, for this particular protein, the complete removal of all bound water molecules leads to difficulties in generating any potential ligands if the unsatisfied hydrogen-bonding sitepoints left by removing these water molecules are to be satisfied by a ligand. As more of the crystallographically determined water molecules are allowed in the binding site, it becomes much easier to generate ligands in larger numbers and with wider chemical diversity. This example shows that, in some cases, bound water molecules can be more accessible for hydrogen bonding to an incoming ligand than the actual protein binding sitepoints associated with them. From the point of view of de novo ligand design, water molecules can thus act as versatile amphiprotic hydrogen-bonding sitepoints and reduce the conformational constraints of a particular binding site.
Mancera
Ricardo L
RL
De Novo Pharmaceuticals Ltd., Compass House, Vision Park, Chivers Way, Histon, Cambridge CB4 9ZR, United Kingdom. Ricardo.Mancera@denovopharma.com
D001419:Bacteria / Q000201:enzymology*; D015195:Drug Design; D006860:Hydrogen Bonding; D008024:Ligands; D009439:Neuraminidase / Q000737:chemistry / Q000378:metabolism*; D014867:Water / Q000737:chemistry*
D008024:Ligands; D014867:Water; D009439:Neuraminidase